SlimTarget Medical

Focused Ultrasound-based Weight Loss Treatment

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo Founded 2021
Total raised
Last: Seed 2022-01
Stage
Seed
Founded
2021
Headcount
6
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

SlimTarget Medical is applying proven focused ultrasound technology to curb appetite and achieve weight loss in overweight patients who also suffer from chronic conditions such as diabetes and high blood pressure. SlimTarget Medical's MRI-guided treatment applies a focused ultrasound beam to ablate a carefully defined point in the brain that has been shown to increase appetite in patients. The delicate ablation procedure is performed applying a proven FDA-approved method. Current trials are demonstrating that the one to two-hour noninvasive procedure is precise, painless, requires no hospitalization or medications, and has long-term effect, making it a viable and attractive alternative to bariatric surgery. It aims to reduce the number of invasive bariatric surgeries and associated complications, as well as the costs and the time of treatment.

Funding history · 1 round · — total

2022-01
Seed Undisclosed

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is SlimTarget Medical's primary focus?
SlimTarget Medical focuses on applying focused ultrasound technology to curb appetite and achieve weight loss in overweight patients, particularly those with chronic conditions like diabetes and high blood pressure.
What technology does SlimTarget Medical utilize for its treatment?
SlimTarget Medical uses MRI-guided focused ultrasound technology to ablate a specific point in the brain associated with increased appetite.
When was SlimTarget Medical founded?
SlimTarget Medical was founded in January 2021.
What is the current employee count for SlimTarget Medical?
SlimTarget Medical currently has 6 employees.
What is the current stage of SlimTarget Medical's product development?
SlimTarget Medical's product is currently in the R&D stage.
What is the duration and nature of SlimTarget Medical's treatment procedure?
The treatment procedure is a one to two-hour noninvasive procedure that is precise, painless, and does not require hospitalization or medications.
What is the primary goal of SlimTarget Medical's treatment?
SlimTarget Medical aims to provide a viable alternative to bariatric surgery, reducing invasive procedures, associated complications, costs, and treatment time.
Which investor led SlimTarget Medical's Seed funding round?
Israel MedicUp led SlimTarget Medical's Seed funding round in January 2022.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsLife Support
Technologies
Simulation & ImagingUltrasound
Target customers
Healthcare & Life SciencesHealthcarePatientsMedical Devices IndustryMedical Equipment

Tags

hospitalsdiabetesobesitymedical-deviceslife-sciencesultrasound